Clostridium Difficile Infection CDI: Difference between revisions

Jump to:navigation,search
No edit summary
No edit summary
Line 7: Line 7:
== Introduction ==
== Introduction ==
[[File:Clostridium difficile CDC.jpeg|thumb|Clostridium difficile]]
[[File:Clostridium difficile CDC.jpeg|thumb|Clostridium difficile]]
Clostridium difficile isa type of[[Bacterial Infections|bacteria]] that can cause colitis, a serious [[Inflammation Acute and Chronic|inflammation]] of the colon. [[Infectious Disease|Infections]] from C.diffoften start after taking [[antibiotics]].It有时会危及生命的< ref name = ": 0 " >吗b md Clostridium difficile Available:https://www.webmd.com/digestive-disorders/clostridium-difficile-colitis (accessed 12.5.2022)
Clostridium Difficile Infections (CDI) are considered one of the most significant nosocomial infections which affect all hospitals worldwide.Clostridium difficile(C. Difficile)isan anaerobic, gram-positive, spore-forming bacillus[[Bacterial Infections|bacteria]] that can cause colitis, a serious [[Inflammation Acute and Chronic|inflammation]] of the colon. [[Infectious Disease|Infections]] from C.difficileoften start afterover-taking [[antibiotics]]and有时会危及生命的< ref name = ": 0 " >吗b md Clostridium difficile Available:https://www.webmd.com/digestive-disorders/clostridium-difficile-colitis (accessed 12.5.2022). This rode shaped bacterium exists in vegetative or spore form and can survive harsh environments and common sterilization techniques. Clostridium difficile is resistant to ultra-violent light, high temperatures, and antibiotics.Cecil J. Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures. Current Infectious Disease Reports [serial online]. December 2012;14(6):612-619. Available from: MEDLINE, Ipswich, MA. Accessed March 17, 2014
* Clostridium difficile is an anerobic, gram-positive bacillus.This rode shaped bacterium exists in vegetative or spore form and can survive harsh environments and common sterilization techniques. Clostridium difficile is resistant to ultra-violent light, high temperatures, and antibiotics.Cecil J. Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures. Current Infectious Disease Reports [serial online]. December 2012;14(6):612-619. Available from: MEDLINE, Ipswich, MA. Accessed March 17, 2014


== Epidemiology ==
== Epidemiology ==
Clostridium difficile infection (CDI) has become a serious medical and epidemiological problem, especially in well developed countries. There has been evident increase in incidenceandseverityofCDIPrevention, proper diagnosisandeffective treatment are necessary to reduce the risk forthe patients,deplete the spreading ofinfectionand diminish the probabilityofrecurrent infectionAntibiotics arethefundamental treatmentof CDIKukla M,Adrych K,Dobrowolska A,Mach T,Reguła J,Rydzewska GGuidelines forClostridium difficile infection inadultsPrzeglad gastroenterologiczny2020;15(1):1Available:https://wwwncbinlmnihgov/pmc/articles/PMC7089862/ (accessed 1252022)
Clostridium difficile infection (CDI) has become a serious medical and epidemiological problemwith approximately 5% of adultsand15 to 70%ofchildren being colonized by Cdifficileand thecolonization prevalence further increases with hospitalized patients andpatientsin nursing homesLeffler DA,Lamont JT. Clostridium difficileinfection.New England JournalofMedicine. 2015 Apr 16;372(16):1539-48.Also, patients abovetheageof65 are more at risk at developingCDIthan younger patientsCzepiel J, Kędzierska J,Biesiada G,Birczyńska M,Perucki W,Nowak P,Garlicki AEpidemiology ofClostridium difficile infection: results of a hospital-based studyinKrakow, PolandEpidemiology & Infection2015 Nov;143(15):3235-43</ref>The incidence of CDIs also depends on the length of the hospitalization period where during the first few days of hospitalization the risk is between 21 to 20% and longer periods of hospitalization increase the risk to up to 454% of getting CDIHung YP, Lin HJ, Wu TC, Liu HC, Lee JC, Lee CI, Wu YH, Wan L, Tsai PJ, Ko WCRisk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposurePloS one2013 Jul 25;8(7):e69577.2015年,美国疾病控制中心和前vention (CDC) found that C. difficile caused half a million infections and resulted in 15,000 deaths in a single yearMedical news today What to know about Clostridium difficile Available:https://www.medicalnewstoday.com/articles/172329#what-is-c-difficile (accessed 12.5.2022).Prevention, proper diagnosis and effective treatment are necessary to reduce the risk for the patients, deplete the spreading of infection and diminish the probability of recurrent infection
2015年,美国疾病控制中心和前vention (CDC) found that C. difficile caused half a million infections and resulted in 15,000 deaths in a single yearMedical news today What to know about Clostridium difficile Available:https://www.medicalnewstoday.com/articles/172329#what-is-c-difficile (accessed 12.5.2022).


== Etiology ==
== Etiology ==
[[File:Hand hygeine.jpg|thumb|Handhygeine]]
[[File:Hand hygeine.jpg|thumb|HandHygiene]]
C. diff exists all around us, being in the air, water, soil, and in the feces of humans and animals. C. diff bacteria that are outside the body turn into spores that can live on surfaces for weeks or months. These spores are dormant but they can become active after ingestion, getting into the intestines. C. difficile also naturally occurs in the gut. When the bacterium is present at normal levels, it is not considered to be an infection.
C. diff exists all around us, being in the air, water, soil, and in the feces of humans and animals. C. diff bacteria that are outside the body turn into spores that can live on surfaces for weeks or months. These spores are dormant but they can become active after ingestion, getting into the intestines. C. difficile also naturally occurs in the gut. When the bacterium is present at normal levels, it is not considered to be an infection.



Revision as of 20:49, 24 February 2023

==Page Under Review== This article is currently under review and may not be up to date. Please come back soon to see the finished work! (24/02/2023)

Introduction[edit|edit source]

Clostridium difficile

Clostridium Difficile Infections (CDI) are considered one of the most significant nosocomial infections which affect all hospitals worldwide. Clostridium difficile (C. Difficile) is an anaerobic, gram-positive, spore-forming bacillusbacteriathat can cause colitis, a seriousinflammationof the colon.Infectionsfrom C. difficile often start after over-takingantibioticsand can sometimes be life-threatening[1].This rode shaped bacterium exists in vegetative or spore form and can survive harsh environments and common sterilization techniques. Clostridium difficile is resistant to ultra-violent light, high temperatures, and antibiotics.[2]

Epidemiology[edit|edit source]

Clostridium difficile infection (CDI) has become a serious medical and epidemiological problem with approximately 5% of adults and 15 to 70% of children being colonized by C. difficile and the colonization prevalence further increases with hospitalized patients and patients in nursing homes[3].Also, patients above the age of 65 are more at risk at developing CDI than younger patients[4].The incidence of CDIs also depends on the length of the hospitalization period where during the first few days of hospitalization the risk is between 2.1 to 20% and longer periods of hospitalization increase the risk to up to 45.4% of getting CDI[5].2015年,美国疾病控制中心和前vention (CDC) found that C. difficile caused half a million infections and resulted in 15,000 deaths in a single year[6].Prevention, proper diagnosis and effective treatment are necessary to reduce the risk for the patients, deplete the spreading of infection and diminish the probability of recurrent infection.

Etiology[edit|edit source]

Hand Hygiene

C. diff exists all around us, being in the air, water, soil, and in the feces of humans and animals. C. diff bacteria that are outside the body turn into spores that can live on surfaces for weeks or months. These spores are dormant but they can become active after ingestion, getting into the intestines. C. difficile also naturally occurs in the gut. When the bacterium is present at normal levels, it is not considered to be an infection.

This bacterium does not usually cause problems for people who are otherwise healthy. However, some antibiotics may alter the balance of bacteria in the gut, allowing C. difficile to multiply. It is at this stage that it becomes an infection. The infection can cause diarrhea and increase the risk of more serious illnesses.

Most cases of C. difficile infection occur in healthcare environments, the link here being with antibiotic therapy[6]

Risk Factors[edit|edit source]

C. diff can affect anyone, however cases of C. diff occur when taking antibiotics or not long after finishing taking antibiotics.

Other risk factorsinclude :

Characteristics/Clinical Presentation[edit|edit source]

Symptoms may develop within a few days after taking antibiotics, and include:

  • Severe diarrhea
  • Fever
  • Stomach tenderness or pain
  • Loss of appetite
  • Nausea[7]

In a more serious case symptoms peritonitis,septicemia, or perforation of the colon may occur. The risk of experiencing a life threatening condition is higher among older people and those with serious health conditions. Symptoms include:

Diagnosis[edit|edit source]

For definitive diagnosis a stool sample must be collected. Tests include:

  • Enzymeimmunoassay
  • Polymerase chain reaction
  • GDH/EIA
  • Cell cytotoxicity assay

If a serious problems with the colon is suspected, an X-rays or a CT scan of the intestines may be ordered. In rare cases, the doctor may examine the colon with procedures such as a flexible sigmoidoscopy or colonoscopy[1]

Medical Management[edit|edit source]

Standard treatment for a C. difficile infection is antibiotics. If a person is taking antibiotics when symptoms appear, a doctor may consider stopping that course and prescribing a new type. However, treatment with antibiotics may make a C. difficile infection worse by attacking the helpful bacteria in the body.

Alternative therapies include:

  • Probiotics: used to help restore a healthful balance in the intestine. Saccharomyces boulardii (S. boulardii), a natural yeast, can reduce recurring C. difficile infections when a person takes it together with antibiotics. S. boulardii probiotics are available for purchase online.
  • Surgery: If symptoms are severe, or if there is organ failure or perforation of the lining of the abdominal wall, it may be necessary to surgically remove the affected part of the colon.
  • Fecal microbiota transplantation (FMT): Medical professionals are now using fecal transplants in recurrent cases of C. difficile infection. A healthcare provider will transfer bacteria from a healthy person’s colon into the colon of a person with C. difficile[6]

Physical Therapy Management[edit|edit source]

C. difficile infections are primarily managed through pharmaceutical therapy and associated medical treatments.

The therapist should take an active role ininfection controland prevention measures whenever working with these patients. Infection control measures include: donning gloves and gowns prior to entering patients room, washing hands with soap and water upon departure, treating patients in a private room, educating visitors on proper hygiene measures. Routine environmental screening and use of chlorine-containing cleaning agents is also recommended.

C. difficile spreads.png

References[edit|edit source]

  1. 1.01.1Web md Clostridium difficile Available:https://www.webmd.com/digestive-disorders/clostridium-difficile-colitis(accessed 12.5.2022)
  2. Cecil J. Clostridium difficile: Changing Epidemiology, Treatment and Infection Prevention Measures. Current Infectious Disease Reports [serial online]. December 2012;14(6):612-619. Available from: MEDLINE, Ipswich, MA. Accessed March 17, 2014
  3. Leffler DA, Lamont JT. Clostridium difficile infection. New England Journal of Medicine. 2015 Apr 16;372(16):1539-48.
  4. Czepiel J, Kędzierska J, Biesiada G, Birczyńska M, Perucki W, Nowak P, Garlicki A. Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland. Epidemiology & Infection. 2015 Nov;143(15):3235-43.
  5. Hung YP, Lin HJ, Wu TC, Liu HC, Lee JC, Lee CI, Wu YH, Wan L, Tsai PJ, Ko WC. Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure. PloS one. 2013 Jul 25;8(7):e69577.
  6. 6.06.16.26.3Medical news today What to know about Clostridium difficile Available:https://www.medicalnewstoday.com/articles/172329#what-is-c-difficile(accessed 12.5.2022)
  7. 7.07.1CDC C. diff (Clostridioides difficile) Available:https://www.cdc.gov/cdiff/what-is.html(accessed 12.5.2022)